Impact of GSE and Xylitol (Xlear) on COVID-19 Symptoms and Time to PCR Negativisation in COVID-19 Patients

Evaluation of Activity and Safety of Oral Selinexor in Participants With Severe COVID-19 Infection

NCT04349098 ·Status: COMPLETED ·Phase: PHASE2

Effects of Early Use of Nitazoxanide in Patients With COVID-19

NCT04552483 ·Status: COMPLETED ·Phase: PHASE2

A Phase III Confirmatory Study of K-237

NCT05056883 ·Status: COMPLETED ·Phase: PHASE3

Study of the Safety, Tolerability and Efficacy of NP-101 in Treating High Risk Participants Who Are Covid-19 Positive.

NCT05785390 ·Status: TERMINATED ·Phase: PHASE2

Clinical Trial to Evaluate the Safety of RQ-01 in SARS-CoV-2 Positive Subjects

NCT06063330 ·Status: COMPLETED ·Phase: PHASE1

Experimental Trial of rhIFNα Nasal Drops to Prevent 2019-nCOV in Medical Staff

NCT04320238 ·Status: UNKNOWN ·Phase: PHASE3

IRAK 4 Inhibitor (PF-06650833) in Hospitalized Patients With COVID-19 Pneumonia and Exuberant Inflammation.

NCT04933799 ·Status: UNKNOWN ·Phase: PHASE2

A Study of a Potential Oral Treatment to Prevent COVID-19 in Adults Who Are Exposed to Household Member(s) With a Confirmed Symptomatic COVID-19 Infection

NCT05047601 ·Status: COMPLETED ·Phase: PHASE2/PHASE3

Safety and Preliminary Efficacy Study of GX-I7 in Patients With COVID-19

NCT04730427 ·Status: TERMINATED ·Phase: PHASE1

A Study to Assess the Efficacy and Safety of XC221 in Patients With COVID-19

NCT04487574 ·Status: COMPLETED ·Phase: PHASE3

Trial to Evaluate the Efficacy and Safety of Nitazoxanide (NTZ) for Pre- and Post Exposure Prophylaxis of COVID-19 and Other Viral Respiratory Illnesses (VRI) in Healthcare Workers and Others at Increased Risk of SARS-CoV-2 Infection

NCT04359680 ·Status: COMPLETED ·Phase: PHASE3

Covid-19 Infection and Pulmonary Distress Treatment With Zanubrutinib in Hospitalized Participants

NCT04382586 ·Status: COMPLETED ·Phase: PHASE2

Study to Evaluate the Safety and Efficacy of Liquid Alpha1-Proteinase Inhibitor (Human) in Hospitalized Participants With Coronavirus Disease (COVID-19)

NCT04547140 ·Status: TERMINATED ·Phase: PHASE2

Efficacy and Safety of Molnupiravir (MK-4482) in Hospitalized Adult Participants With COVID-19 (MK-4482-001)

NCT04575584 ·Status: TERMINATED ·Phase: PHASE2/PHASE3

Safety and Immunogenicity Evaluation of the Recombinant Flagellin Protein Adjuvant

NCT06768697 ·Status: NOT_YET_RECRUITING ·Phase: EARLY_PHASE1

The Evaluation of Nitric Oxide Generating Lozenges on Outcome in Newly Diagnosed COVID-19 Patient of African American and Hispanic Origin

NCT04601077 ·Status: TERMINATED ·Phase: PHASE1/PHASE2

Administration of Anti-SARS-CoV-2 Convalescent Plasma in Hospitalized, Non-ICU Patients With COVID-19

NCT04467151 ·Status: WITHDRAWN ·Phase: PHASE2

COVID-19 and Anti-CD14 Treatment Trial

NCT04391309 ·Status: TERMINATED ·Phase: PHASE2

Clinical Effect of Dialyzable Leukocyte Extract in Suspected or Confirmed Cases of COVID-19 (FUTURE-T)

NCT04379479 ·Status: UNKNOWN ·Phase: PHASE2

A Study to Evaluate the Efficacy and Safety of ZX-7101A Tablets in Adults with Uncomplicated Influenza

NCT05702489 ·Status: COMPLETED ·Phase: PHASE2/PHASE3

Efficacy of Tocilizumab on Patients With COVID-19

NCT04356937 ·Status: COMPLETED ·Phase: PHASE3

A Study of S-892216 in Participants With COVID-19

NCT06928051 ·Status: COMPLETED ·Phase: PHASE2

Colchicine in Patients With Mild and Severe Coronavirus Disease

NCT04367168 ·Status: TERMINATED ·Phase: PHASE2

New Antiviral Drugs for Treatment of COVID-19

NCT04392427 ·Status: UNKNOWN ·Phase: PHASE3

Effect of Hypertonic Saturated Saline Mouth Rinse on Covid-19 Virus in Vivo.

NCT04842721 ·Status: WITHDRAWN ·Phase: PHASE2